跳至主要内容
临床试验/CTRI/2026/04/109467
CTRI/2026/04/109467尚未招募3 期

A clinical evaluation of abhirumuladi avaleha in the management of autism spectrum disorder (ASD)

Shri Babu Singh Jay Singh Ayurvediuc Medical College And Hospital1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2026年5月15日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
15
试验地点
1

研究概览

简要总结

Autism spectrum disorder is a progressive neurodevelopmental disorder characterized by impaired social interaction, communication, and behavioral phenotypes. We are taking abhirumuladhi avleha in the management of ASD for research purposes. Contents of Abhirumuladhi Avleha are helpful to improve cognitive function, concentration and to enhance the quality of life of autistic children

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
5.00 Year(s) 至 16.00 Year(s)(—)
性别
All

入选标准

  • 1.Subjects diagnosed with and presenting complaints of Autism will be taken.
  • Mild to moderate autistic patients will be taken.
  • 3.From the age group of 5 to 16 years of subjects irrespective of gender, caste, socioeconomic status and food habits will be taken.
  • 4.Parents/ guardian willing to give informed written consent to participate in the study.

排除标准

  • 1.Children below 5 years and above 16 years.
  • 2.Severe Autistic Patients.
  • 3.Hearing and visual impairment, Multiple disabilities.
  • 4.Patients with acute and chronic systemic illness such as renal diseases, Hepatic dysfunction, Juvenile diabetes mellitus, malignancy, etc.
  • 5.Progressive and non-progressive neuromuscular disorders, Known neurodegenerative disorder, Cerebral palsy.
  • 6.Children taking anti-epileptic and anti-psychotic drugs.

研究者

发起方
Shri Babu Singh Jay Singh Ayurvediuc Medical College And Hospital
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Jasmine

Shri Babu Singh Jay Singh Ayurvedic Medical College And Hospital,Farrukhabadh

研究点 (1)

Loading locations...

相似试验